Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation.

Eikelboom, J W; Quinlan, D J; Connolly, S J; Hart, R G; Yusuf, S

Eikelboom, J W; Quinlan, D J; Connolly, S J; Hart, R G; Yusuf, S.

J Thromb Haemost ; 10(5): 966-8, 2012 May.

Article in En | MEDLINE | ID: mdl-22360879

Subject(s)

Anticoagulants/therapeutic use; Atrial Fibrillation/drug therapy; Benzimidazoles/therapeutic use; Blood Coagulation/drug effects; Stroke/prevention & control; beta-Alanine/analogs & derivatives; Anticoagulants/adverse effects; Atrial Fibrillation/blood; Atrial Fibrillation/complications; Benzimidazoles/adverse effects; Dabigatran; Evidence-Based Medicine; Humans; Intracranial Hemorrhages/chemically induced; Patient Safety; Risk Assessment; Risk Factors; Stroke/blood; Stroke/etiology; Treatment Outcome; beta-Alanine/adverse effects; beta-Alanine/therapeutic use

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Atrial Fibrillation / Benzimidazoles / Blood Coagulation / Beta-Alanine / Stroke / Anticoagulants Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Thromb Haemost Year: 2012 Document type: Article

Fulltext

XML

PubMed Links

Search on Google